Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stacy A. Crow"'
Autor:
Pritish K. Tosh, Paul J. Jannetto, Stacy A. Crow, Ross A. Dierkhising, Raymund R. Razonable, Brianne M. Ritchie, Erin F. Barreto, Jason N. Barreto
Publikováno v:
Antimicrobial agents and chemotherapy. 63(3)
The clinical utility of ganciclovir therapeutic drug monitoring (TDM) is unknown. We retrospectively analyzed adult patients treated for cytomegalovirus (CMV) infection with ganciclovir with TDM between 2005 and 2015. The primary outcome was an assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1fed2ef22d60a0a54b2c52471e2c7c
https://pubmed.ncbi.nlm.nih.gov/30602515
https://pubmed.ncbi.nlm.nih.gov/30602515
Publikováno v:
Nature Biotechnology, 30(12), 1186-1190. Nature Publishing Group
For authorized biosimilars to achieve full acceptance in the marketplace, it is crucial that they are considered to be therapeutically equivalent and interchangeable with the brand reference product.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6bc1417029d591c41dcb06378a3160
https://pure.eur.nl/en/publications/6d455331-5b4e-475d-931e-f83f5152df47
https://pure.eur.nl/en/publications/6d455331-5b4e-475d-931e-f83f5152df47
Autor:
Arnold G. Vulto, Stacy A. Crow
Publikováno v:
Targeted Oncology
Targeted Oncology, 7, S43-S49. Springer Paris
Targeted Oncology, 7, S43-S49. Springer Paris
Drug licensing and drug safety monitoring for standard chemical entities have been established and are routinely used. These have resulted in a solid foundation of knowledge from which confident therapeutic decisions can be made. For many chemical en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1036f2d69d1f7d87e22a8111085b8ce
https://pure.eur.nl/en/publications/79f98cf5-c35e-4b41-9c17-98fbd0de0725
https://pure.eur.nl/en/publications/79f98cf5-c35e-4b41-9c17-98fbd0de0725
Autor:
Stacy A. Crow, Cindy Little, Angela Q. Maldonado, Neal M. Davies, Okechukwu N. Ojogho, Douglas L. Weeks
Publikováno v:
Transplantation. 91:e3-e4
Although plasmapheresis (PP) is a widely used intervention in immunologic disease states, there is an absence of literature on its effects on the pharmacokinetics of mycophenolic acid (MPA) (1). Supplemental dosing is often necessary for highly prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70e861960b9f6917239d3e3240f83316
https://doi.org/10.1097/tp.0b013e3181fc0a35
https://doi.org/10.1097/tp.0b013e3181fc0a35